InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

Current share price for OCC : $0.570 0.02 (3.64%)+

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$155 Change in substantial holding MC 17 May 2019 9:13AM $0.535 $0.570 risen by 6.54%
$155 Change of Director's Interest Notice MC 17 May 2019 9:06AM $0.535 $0.570 risen by 6.54%
$155 Becoming a substantial holder 16 May 2019 4:31PM $0.535 $0.570 risen by 6.54%
$155 Appendix 3B and Notice Under Section 708A 15 May 2019 4:54PM $0.535 $0.570 risen by 6.54%
$155 First Patients Complete Nerve Regeneration Trial 8 May 2019 8:49AM $0.115 $0.570 risen by 395.65%
$155 Orthocell Submits AUS Regulatory Application for CelGro 1 May 2019 9:04AM $0.115 $0.570 risen by 395.65%
$155 Appendix 4C - Quarterly 30 Apr 2019 6:49PM $0.115 $0.570 risen by 395.65%
$155 Notice of General Meeting/Proxy Form 18 Apr 2019 4:37PM $0.130 $0.570 risen by 338.46%
$155 Appendix 3B and Notice Under Section 708A 8 Apr 2019 10:10AM $0.140 $0.570 risen by 307.14%
$155 Orthocells Ortho-ATI Shoulder Tendon Study on Track 6 Mar 2019 8:50AM $0.140 $0.570 risen by 307.14%
$155 Half Yearly Report and Accounts 27 Feb 2019 6:52PM $0.135 $0.570 risen by 322.22%
$155 Ceasing to be a substantial holder QXZ 15 Feb 2019 4:34PM $0.145 $0.570 risen by 293.10%
$155 Orthocells Ortho-ATI shows 82% success rate 13 Feb 2019 9:43AM $0.150 $0.570 risen by 280%
$155 Appendix 4C - Quarterly 31 Jan 2019 6:08PM $0.130 $0.570 risen by 338.46%
$155 Appendix 3B and Notice Under Section 708A 31 Dec 2018 8:25AM $0.150 $0.570 risen by 280%
$155 Appendix 3B and Notice Under Section 708A 18 Dec 2018 8:16PM $0.160 $0.570 risen by 256.25%
$155 Placement Completion 18 Dec 2018 8:13PM $0.160 $0.570 risen by 256.25%
$155 CelGro Approved in Key UK Public Dental Hospital 11 Dec 2018 9:56AM $0.190 $0.570 risen by 200%
$155 Share Placement Successfully Raises $1.8m 11 Dec 2018 9:54AM $0.190 $0.570 risen by 200%
$155 Trading Halt 7 Dec 2018 9:54AM $0.190 $0.570 risen by 200%
$155 Patient Treatment Completed in Dental Implant Study 28 Nov 2018 10:47AM $0.210 $0.570 risen by 171.43%
$155 OCC Receives New Patents for Celgro Platform Technology 2 Nov 2018 9:55AM $0.235 $0.570 risen by 142.55%
$155 Appendix 4C - Quarterly 31 Oct 2018 6:39PM $0.245 $0.570 risen by 132.65%
$155 Investor Update 31 Oct 2018 10:02AM $0.235 $0.570 risen by 142.55%
$155 Orthocell Secures CelGro Patent Protection in Japan 23 Oct 2018 9:38AM $0.225 $0.570 risen by 153.33%

551 - 575 of 785 results

Page 23 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.